iPS cells: mapping the policy issues.
Given the explosion of research on induced pluripotent stem (iPS) cells, it is timely to consider the various ethical, legal, and social issues engaged by this fast-moving field. Here, we review issues associated with the procurement, basic research, and clinical translation of iPS cells.
Zarzeczny
Amy
A
Health Law Institute, University of Alberta, Edmonton, Alberta T6G 2H5, Canada.
Scott
Christopher
C
Hyun
Insoo
I
Bennett
Jami
J
Chandler
Jennifer
J
Chargé
Sophie
S
Heine
Heather
H
Isasi
Rosario
R
Kato
Kazuto
K
Lovell-Badge
Robin
R
McNagny
Kelly
K
Pei
Duanqing
D
Rossant
Janet
J
Surani
Azim
A
Taylor
Patrick L
PL
Ogbogu
Ubaka
U
Caulfield
Timothy
T
D035843:Biomedical Research; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000166:cytology*; D011640:Public Policy; D033581:Stem Cell Transplantation; D014019:Tissue Donors